JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...
AZ Animals US on MSN
Climbing Fox Outruns Delaware’s Old Symbols—But Why This Animal, Not a Bird?
Delaware’s official wildlife animal is not a bird from its coastal marshes or a creature from the Atlantic surf. Instead, it ...
18hon MSN
CT high school students unearthed the past. ‘It is our history. We’re all connected,’ one said
I think it is showing us…making us focus on what is around us,” a senior said, noting the work, which had students using ...
John J. Raskob — the man behind the Empire State Building and several Wall Street and workplace innovations — in ...
JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 ...
Zenas anticipates submitting a Biologics License Application (BLA) to the FDA in the second quarter of 2026 and a Marketing ...
GlobalData on MSN
Zhejiang Longsheng assumes full control of DyStar
Zhejiang Longsheng Group has acquired full ownership of DyStar, a speciality chemical company, following the resolution of a ...
Discover why zoology is referred to as the 'Scribe of Species.' Discover the various job pathways available to zoologists in ...
Paul Cezanne’s Pommes et oranges (around 1899) is one of the paintings that will show at his self-titled exhibition at ...
Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback